Gene Therapy for Pediatric Neurologic Disease

Area of Science:

• Neurology
• Genetics
• Pediatrics
• Gene Therapy

Background:

• Pediatric lysosomal and peroxisomal storage disorders, leukodystrophies, and motor neuron diseases cause severe neurological symptoms.
• Monogenic disorders affecting children have lacked definitive treatments despite decades of research.
• Cross-correction strategies have shown limited success in treating these conditions.

Purpose of the Study:

• To review the rationale and recent advancements in gene therapy for pediatric neurologic disorders.
• To outline specific genetic disorders targeted by current gene therapy approaches.
• To examine ongoing and recent clinical investigations and future therapeutic directions.

Main Methods:

• Exploration of gene therapy strategies, including transduction of autologous hematopoietic stem cells.
• Review of in vivo gene therapy approaches for delivering therapeutic genes.
• Analysis of recent and current clinical investigations and their methodologies.

Main Results:

• Recent gene therapy efforts focus on transducing hematopoietic stem cells and in vivo gene delivery.
• Several pediatric neurologic disorders are being targeted, with ongoing clinical trials.
• The review synthesizes current findings and identifies future research trajectories.

Conclusions:

• Gene therapy, particularly using stem cell transduction and in vivo methods, shows promise for treating pediatric genetic neurologic disorders.
• Continued clinical investigation is crucial for advancing these novel therapeutic strategies.
• Future efforts will likely focus on refining delivery methods and expanding targeted disorders.